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Abstract 
 
Active Site Structure and Enzyme Activity of a Heme Degradation Enzyme 
from Mycobacterium tuberculosis, MhuD 
 
By 
 
Shusuke Nambu 
 
 
MhuD is an oxygen-dependent heme degrading enzyme from Mycobacterium tuberculosis 
with high sequence similarity to Staphylococcus aureus IsdG and IsdI which has a distinct 
crystal structure, including huge heme distortion, and a distinct tetrapyrrole product from those 
of well-studied heme degrading enzymes, termed heme oxygenase (HO).  It has been 
previously reported that MhuD can bind upto two molecules of heme per a monomer and the 
1:1 complex is enzymatically active but the 2:1 complex is inactive.  Additionally, the crystal 
structure of 2:1 heme-MhuD complex has been characterized but not 1:1 heme-MhuD complex.  
The heme titration of MhuD confirms that MhuD can bind upto two molecules of heme per 
a monomer but the gel filtration test shows the second heme binding is very weak.  The 
resonance Raman and electron paramagnetic resonance studies show that the active site 
structure of 1:1 heme-MhuD complex is similar to that of IsdG and IsdI.   
Spectroscopic and mutagenesis studies indicate that 1:1 heme-MhuD complex possesses a 
ruffled heme, which is a striking feature of IsdG and IsdI, and the axial ligand of the heme is 
His75, a counterpart of His77 and His76 in IsdG and IsdI, respectively, to the heme iron.  
Distinct from the canonical heme degradation, MhuD catalysis does not generate CO, which is 
reveled by the CO detection study using high CO affinity myoglobin, H64L myoglobin.  
Product analyses by electrospray ionization-MS and NMR show that MhuD cleaves heme at 
α-meso position but retains the meso-carbon atom at the cleavage site, which is removed by 
canonical HOs.  The novel tetrapyrrole product of MhuD, termed “mycobilin”, has an 
aldehyde group at the cleavage site and a carbonyl group at either β-meso or the δ-meso position.  
Consequently, MhuD catalysis does not involve verdoheme, the key intermediate of ring 
cleavage by canonical HOs.  Ruffled heme is apparently responsible for the heme degrading 
mechanism unique to MhuD.   
IsdG and IsdI from S. aureus also contain ruffled hemes.  This study demonstrates that 
CO is not the major product in the heme degrading reaction of IsdG and IsdI.  The primary C1 
product of IsdG and IsdI is formaldehyde and the secondary C1 products are formic acid and 
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CO.  These finding clearly reveals that both IsdG and IsdI degrade heme by an unusual 
mechanism distinct from canonical HOs.  I suggest IsdG and IsdI degrade heme by a similar 
mechanism as MhuD and conclude that heme ruffling is critical for the drastic mechanism 
change for these novel bacterial enzymes.   
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1.1. Heme Oxygenases in Mammals 
 
Biological degradation of heme (iron-protoporphyrin IX) plays a variety of crucial 
functions in living organisms (1, 2).  An enzyme termed heme oxygenase (HO) catalyzes 
regiospecific conversion of heme into biliverdin (BV) IXα, carbon monoxide (CO), and a free 
ferrous iron by three successive oxygenation reactions (Fig. 1.1.) (3-6).   
Mammalian HO is a membrane-bound enzyme anchored to the microsomal membrane 
through a C-terminal hydrophobic tail and exists in two major isoforms (7).  HO-1 is 
composed of 288 amino acid residues with a total molecular weight of 33,000 and HO-2 is 
composed of 316 amino acid residues with a total molecular weight of 36,000.  HO-1 is 
induced by chemical agents and a variety of stress conditions, and found in the highest 
concentration in the spleen and liver (8-10).  In contrast, HO-2 is not induced by exogenous 
stimuli and is found in the highest concentration in the brain and testis (11, 12).  Additionally,  
a third isoforrm, HO-3, has been reported but the expressed protein is not active (13).  The 
HO-3 genes are proposed as processed-pseudogenes derived from HO-2 transcripts, and 
therefore the significance of this third form is unclear (14). 
The primary functions of HO-1 are excess heme catabolism and iron homeostasis because 
less than 3% of the daily iron requirement is obtained from the diet (4, 15-17).  HO-1 also has 
the function of antioxidant defense (2).  BV is reduced by biliverdin reductase (BVR) to 
bilirubin (BR) which is subsequently conjugated with glucuronic acid and excreted (18).  BR is 
toxic at high concentrations, however, it may be particularly important as a cytoprotectant for 
tissues with relatively weak endogenous antioxidant defenses such as the myocardium and the 
nervous system (19).  The physiological role of HO-2 has been reported the CO production as 
a neuronal messenger molecule (20).  In vascular smooth muscle cells, CO produced by HO 
regulates cyclic guanosine 3',5'-monophosphate (cGMP) levels, which is an important regulator 
of vessel tone (20-22).  Soluble guanylyl cyclase (sGC) synthesizes cGMP from guanosine 
triphosphate (GTP) and it is activated by NO.  CO could act either to facilitate or to inhibit 
NO-mediated activation of sGC and CO may also play a more prominent role as a mediator of 
blood vessel relaxation by cGMP (1, 23-25).  Also, CO is reported as an inhibitor of 
cystathionine β-synthase (CBS).  CBS catalyzes the condensation of homocysteine and serine 
to cystathionine and is unique in being dependent on both pyridixal 5’-phosphate and heme for 
the activity (26, 27).  CO binds to the ferrous form of CBS to inhibit the enzymatic activity (27, 
28).  As the other function of HO-2, it could be an oxygen sensor that controls 
calcium-sensitive potassium (BK) channels during oxygen deprivation (29, 30).  BK channels 
are strongly implicated in the acute of oxygen signaling cascade of a number of cellular systems 
and low arterial oxygen is detected by BK channels in carotid body, and the resulting 
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depolarizing signal is ultimately transduced into increased ventilation.  It is suggested that CO 
produced by HO-2 is the physiological messenger to BK channel.  
 
 
Figure 1.1. Heme degradation catalyzed by HO 
 
 
1.2. Heme Oxygenases in Bacteria 
 
Most pathogenic bacteria have an absolute requirement for iron, a nutrient that is scare 
within the human host (31).  Many bacteria produce and secrete small and high affinity iron 
chelating compounds called siderophore to scavenge for ferric iron (32, 33).  Siderophores 
form tight and stable complex with ferric iron which is poorly soluble and recognized and 
transported to the cytoplasm by the specific proteins (34, 35).  Heme oxygenase have been also 
identified in some pathogenic bacteria where heme degradation is employed to acquire iron, an 
essential nutrient required for survival and infection, from host heme molecules to circumvent 
the low concentration of free extracellular iron (36-38).  The following enzymes have been 
characterized as bacterial HOs: HmuO from Corynebacterium diphtheria, HemO from 
Neisseria meningitides, and PigA from Pseudomonas aeruginosa (36, 39, 40).  Bacterial HOs 
are not membrane-bound, but soluble enzymes.  Their molecular weights are 25,000 on 
average, which is slightly smaller than mammalian HOs, because they lack the C-terminal 
membrane anchor region.  HmuO and HemO catalyze the conversion of heme to BV IXα but 
PigA produces BV IXβ and IXδ which are regiospecific isomers of BV IXα (Fig. 1.2.).  
Additionally, more HOs have been identified in bacteria but their physiological properties are 
not iron acquisition.  BphO from Pseudomonas aeruginosa is second HO in the bacteria and it 
produces BV IXα whose physiological function has been suggested to be a precursor of 
bacteriophytochrome (40).  Pseudomonas aeruginosa is the first example of an organism that 
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harbors two HOs with different regiospecificity of heme cleavage.  Cyanobacterial HO-1 and 
HO-2 catalyze the conversion of heme to BV IXα which is the precursor of phytobilins (41). 
Phycobilins are linear tetrapyrrole molecules that are the precursors of the chromophores for the 
light-harvesting phycobiliproteins and the photoreceptor phytochrome (42-44). 
 
 
Figure 1.2. Structures of (A) biliverdin IXβ and (B) IXδ 
 
 
1.3. Heme Degrading Mechanism of HO 
 
HO oxidation consumes a total of three molecules of O2 and seven electrons.  In mammals, 
the electrons required for the catalytic turnover are provided by NADPH-cytochrome P450 
reductase (CPR) (45), whereas in plants, ferredoxin and ferredoxin-NADP
+
 oxidoreductase are 
employed.  Physiological electron donors for pathogenic bacterial HO have yet to be identified, 
but CPR or ascorbate can support the activities of most of them in vitro.  After the enzyme 
binds ferric-heme, one electron is donated by the reducing substrate, converting heme-iron to 
the ferrous form (Fig. 1.3.).  Then O2 binds, the first oxygenation of the reaction, to the 
reduced pentacoordinate heme to form a meta-stable oxy complex.  A one electron reduction of 
the oxy form generates a ferric-hydroperoxo complex, which self-hydroxylates the 
α-meso-carbon of the porphyrin ring (46).  This is different from what occurs in P450 enzymes, 
in which the O‒ O bond of the hydroperoxo complex is heterolytically cleaved to generate an 
actively hydroxylating ferryl (Fe
4+
=O) intermediate called compound I.  It has been reported 
that protonation of ferric-hydroperoxo by a distal water molecule is critical in promoting the 
self-hydroxylation (47).  The second oxygenation is a rapid, spontaneous auto-oxidation of the 
reactive α-meso-hydroxyheme.  The mechanism of the second step remains elusive, but the HO 
enzyme has been shown not to play a critical role in it, meaning hydroxyheme immediately 
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react with O2 to afford verdoheme even in the absence of HO (48).  The third O2 activation, by 
verdoheme, cleaves its porphyrin macrocycle to release biliverdin and free ferrous iron.  It has 
been strongly suggested that ferric-hydroperoxo species as a key intermediate of the ring 
opening (6).  This mechanism is very similar to that of the first meso-hydroxylation, including 
the critical roles of the distal water molecule.   
 
 
Figure 1.3. Schematic of heme oxygenase catalytic intermediates. 
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1.4. Crystal Structures of HOs 
 
The first crystal structure of HO was reported for human HO-1 (Fig. 1.4.) (49).  The fold 
of HO is a single compact domain consisting of mostly α helices and the heme is sandwiched 
between two helices termed the proximal and distal helices, with the δ-meso (or β-meso) edge 
and the propionates exposed at the molecular surface.  Overall, the structures of ratHO-1, 
HmuO, HemO, PigA, and Syn HO-1 and Syn HO-2 from cyanobacterium Synechocystis sp. 
PCC 6803, are very similar to that of human HO-1 (Fig. 1.5.) (50-55).  All the HO proteins 
listed above are monomeric except for Syn HO-2 which forms a homodimeric through the 
interaction of the extended C-terminal segments.  The physiological significance of 
dimerization, however, has yet to be elucidated (55).  Two helices, the proximal and distal 
helices, contribute most of the contacts to the heme group.  Because both helices deviate 
substantially from the geometry of an ideal helix, they can be referred to as bent helices or as a 
group of consecutive smaller helices.  The proximal helix contains His25 (in mammalian HO-1 
sequence), which is the proximal heme ligand.  The distal helix is kinked owing to the highly 
conserved Gly rich motif ‒ YLGDLSGGQ‒  (but the sequence is not strictly conserved in 
HemO and PigA).  The Gly rich motif also enables the distal helix to be flexible.  The 
flexibility seems to be important to open the active site to allow easy entry of the substrate and 
exit of the products (56). 
 
 
Figure 1.4. (A) Crystal structure of human HO-1 and (B) its active site. PDB code: 1N45 
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Figure 1.5. Crystal structures of (A) rat HO-1, (B) HmuO, (C) HemO, (D) PigA, (E) Sync HO-1, 
and (F) Sync HO-2. (PDB codes are: 1DVE, 1IWO, 1J77, 1SK7, 1WE1, and 1WOV, 
respectively) 
 
 
In all the crystal structures of the heme-HO complexes, the ferric heme iron is 
hexacoordinated with an ε-nitrogen atom of imidazole group of histidine and an oxygen atom of 
water as the axial ligands (57-59).  The proximal His-iron interaction does not seem to be a 
prime factor for the binding of heme to HO because the H25A HO-1 and H20A HmuO mutants, 
where proximal His is replaced by Ala, form stoichiometric complexes with heme (60-62).  
The H25A and H20A variants, however, are catalytically inactive, indicating the significance of 
the proximal His residue (60, 63).   
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The distal pocket of heme also takes an important role for the catalytic activities.  About 
the distal structure of HO, crystal structures of heme‒ HO complexes, especially a ferrous-O2 
complex of HmuO reveal salient structural aspects that govern the regiospecific 
meso-hydroxylation (49, 50, 64).  The axial ligand His is neutral and thus does not enhance 
cleavage of the O‒ O bond leading to compound I formation unlike the more anionic His ligand 
in peroxidases (57).  The distal helix of HO is kinked above the heme plane around two 
conserved Gly residues and is in close contact with the heme group to sterically restrict access 
to all the meso positions except for the α-meso-carbon.  As a result, the steric constraints 
imposed by the distal helix direct the terminal oxygen atom of the ferrous-O2 complex toward 
the heme α-meso-carbon.  Additionally, some water molecules play critical roles in HOs.  The 
water molecules consists the hydrogen bonding network which extends from the distal pocket 
through the enzyme to its surface and the channel may funnel the required protons to the active 
site in a controlled manner (65-67).  At the heme distal pocket, the terminal oxygen atom also 
interacts with a water molecule (Wat1 in Fig. 1.6.), which is part of a distal hydrogen bond 
network including a water cluster and a catalytically critical Asp residue (Asp136 in HmuO).  
The distal Asp, which is conserved in most mammalian and bacterial HOs, interacts with heme 
ligand through intervening water molecules, which are Wat1 and Wat2 in Fig. 1.6. (49, 50, 52).  
Distal Asp in mammalian HO-1 is indispensable for the meso-hydroxylation, suggesting direct 
involvement of the carboxylate moiety in the oxygen activation (68, 69).  In addition, distal 
Asp of HmuO can be replaced by Asn without significant loss of the enzyme activity.  It has 
been suggested that the distal Asp is not involved in the oxygen activation but stabilizes the 
water network to place catalytically critical water molecule at a position suitable for efficient 
Fe‒ OOH activation.  
The crystal structure of heme-PigA complex shows an unusual seating of the heme, which 
is rotated by about 100° counterclockwise relative to its position in other HOs (53).  This 
rotation places the δ-meso-carbon in the position normally occupied by the α-meso-carbon in 
other HOs.  The unusual conformation of heme binding gives the unusual regioselective 
products BV IXδ for PigA.  Furthermore, PigA does not only produce BV IXδ but also BV IXβ 
because heme is pseudo-symmetric along the α-γ axis.  β-meso position can locate on the 
δ-meso position at the heme binding site by rotating heme along the α-γ axis, leading cleavage 
of δ and β-meso position as a pair to form isomers of tetrapyrrole products.   
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Figure 1.6. Heme environment of crystal structure of the 
ferrous-O2 heme-HmuO complex. Red balls represent oxygen 
atoms of water molecules.  PDB code: 1V8X 
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1.5. Non-HO Type Heme Degrading Enzyme 
 
Nowadays, two non-HO type heme degrading enzymes, HugZ-type enzymes and IsdG-type 
enzymes, have been identified.   
First, HugZ-type enzyme families have been identified from Helicobacter pylori, Vibrio 
cholera, and Campylobacter jejuni, named HugZ, HutZ, and Cj1613c, respectively (70-72).  
HugZ and Cj1613c are homologous (56% sequence identity) but not to other HOs.    
Interestingly, sequence alignments show that they have weak sequence similarities with 
FMN-binding proteins with a split-barrel fold. HutZ also shows 59% sequence identity with 
HugZ (73).  It is proposed that HutZ degrades heme transported by three outer membrane 
receptors, HutA, HutR, and HasR in Vibrio cholera (74-76).  The crystal structure of HugZ has 
been characterized and it is actually similar to FMN-binding protein but distinct from canonical 
HOs (Fig. 1.7.) (77).  HugZ exists as a homodimer in solution and in crystals, and the dimer 
adopts a split-barrel fold that is often found in FMN-binding proteins.  The heme is located at 
the intermonomer interface and is bound by both monomers (Fig. 1.7.).  The heme is 
coordinated by His245 at a flexible C-terminal loop region and His245 is not required for the 
catalytic activities but it is proposed only responsible for the recognition (77).  It is a unique 
character of HugZ because canonical HOs have His as the axial ligand at rather rigid heme 
binding pocket and His is crucial for the catalytic activity.  On the other hand, Arg166, which 
is located at the distal site of the heme, is essential for the catalytic reaction and is proposed 
maintaining the water network (77).  The heme degrading products of HugZ and HutZ are 
similar to canonical HOs, BV IXδ for HugZ and BV IXβ and IXδ for HutZ, although the crystal 
structures and the heme binding site structures of HugZ and HutZ are distinct from those of the 
HOs (70, 78).  The same feature about the product is able to be found in one of HO, PigA 
produces BV IXβ and IXδ.  The heme degrading product of Cj1613c has been unknown.  The 
heme degradation mechanism of HugZ-type enzymes has not been characterized but it probably 
the same as that of canonical HOs because the tetrapyrrole products of HugZ-type enzymes are 
regiospecific BVs.  Additionally, the formation of verdoheme has been identified in HutZ 
heme degradation (78).  HutZ-type enzymes probably degrade heme through the 
meso-hydroxylation of heme and the ring opening of the verdoheme intermediate.   
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Figure 1.7. (A) Crystal structure of HugZ dimer and (B) its heme binding site. The two 
monomers are displayed in red and green.  PDB code: 3GAS 
 
 
Second, IsdG-type enzymes have been also identified from Staphylococcus aureus, 
Bacillus anthracis, Bradyrhizobium japonicum, and Mycobacterium tuberculosis (79-82).  S. 
aureus IsdG and IsdI have been studied well among them and it is clarified that they have 
distinct crystal structures and non-BV products (80, 83).  One of the most striking structural 
features of the IsdG and IsdI is the severe distortion of the heme plane, best described as 
“ruffled”, in contrast to the flat heme in HO (Fig. 1.8.) (83, 84).  Heme ruffling should have 
significant effects on the IsdG catalysis because enzyme-bound heme activates molecular 
oxygen for self-decomposition as established for canonical HO reactions. The other features of 
IsdG and IsdI are they afford a non-biliverdin chromophore called staphylobilin (Fig. 1.9.) (83).  
Staphylobilin is different from biliverdin in the site of ring cleavage (β- or δ-meso cleavage 
rather than α-meso cleavage in biliverdin) and in the additional oxidation of the meso-carbon at 
the opposite side to have a δ- or β-meso carbonyl group.  The heme degrading mechanism of 
IsdG type-enzymes has been proposed, based on the structure of staphylobilin (83), but any 
studies have not been carried out to prove the proposed mechanism.  Wherein, I am interested 
in the heme degrading mechanism of IsdG-type enzymes rather than that of HugZ-type enzymes.  
The reason is I expected that IsdG-type enzymes has distinct heme degrading mechanism from 
canonical HOs because their tetrapyrrole products is not BV, any intermediates like verdoheme 
have not been identified, and especially, the hemes bound to IsdG-type enzymes are distorted.   
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Figure 1.8. Crystal structures of N7A IsdG (A) and IsdI (B). Heme environments structure of 
N7A IsdG (C) and IsdI (D) with residues that interact with the porphyrin rings. PDB codes are: 
2ZDO for N7A IsdG and 3LGN for IsdI. 
 
 
 
Figure 1.9. Structures of staphylobilin isomers. 
(A) 15-oxo-β-bilirubin and (B) 5-oxo-δ-bilirubin. 
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1.6. IsdG-type Heme Degrading Enzymes 
 
S. aureus IsdG and IsdI are part of a heme uptake pathway called the iron-regulated surface 
determinant system (Isd system) (85).  Isd system involves nine proteins encoded by S. aureus 
for heme uptake (Fig. 1.8.).  IsdA, IsdB, IsdC and IsdH are cell wall anchored surface 
receptors (85-88).  IsdE and IsdF comprise the binding protein and permease components of an 
ABC transporter, respectively (85, 89).  IsdD is a predicted membrane protein of unknown 
function yet has been suggested to interact with IsdE and IsdF as part of the membrane 
transporter (90).  Finally, IsdG and IsdI are cytoplasmic heme degrading enzymes that liberate 
the central iron atom for use by the organism (80). 
 
 
Figure 1.10. Schematic representation of the Isd system heme transport 
components.  Hb is abbreviated hemoglobin. 
 
 
IsdG is composed of 108 amino acid residues with a total molecular weight of 12,546 and 
IsdI is composed of 109 amino acid residues with a total molecular weight of 12,791.  IsdG 
and IsdI are highly homologous proteins sharing 64% sequence identify and 78% sequence 
similarity at the amino acid level (Fig.1.11.) (80). 
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Figure 1.11. Sequence alignments of M.tuberculosis MhuD, S. aureus 
IsdG, and S. aureus IsdI. Conserved catalytic residues are in red. 
 
  
The crystal structures of IsdG and IsdI are distinct from those of HO-type enzymes as 
expected from their low sequence similarity.  IsdG and IsdI are composed by four β-sheets and 
three α-helices mainly, in the other hand, canonical HOs are composed by only some α-helices 
(Fig.1.5. and 1.8.).  The crystal structures of IsdG and IsdI are very similar to each other, being 
superimposable with a root mean square deviation of less than 1 Å although the crystal structure 
of N7A variant is only characterized but not wild-type about IsdG (84).  The amino acids 
residues composing the active sites are well conserved between IsdG and IsdI (Fig.1.11.).  The 
ferric iron atom of the heme is pentacoordinate with His77 and His76 for IsdG and IsdI, 
respectively (Fig. 1.8).  Asn residue (Asn7 for IsdG and Asn6 for IsdI) is located at the distal 
side of the heme and N7A and N6A variants lost their heme degrading activities (91).  One of 
the most striking structural features of the IsdG and IsdI is the severe distortion of the heme 
plane, best described as “ruffled”, as mentioned above.  It is reported that Trp residue (Trp67 
for IsdG and Trp66 for IsdI) is a key to retain ruffling and the Trp variants diminishes the heme 
ruffling and the enzymatic activity (92).  It is remarkable feature to consider the heme 
degrading mechanism of IsdG and IsdI because it has been reported heme distortion is shown to 
contribute markedly to IsdI enzyme activity (92).   
Staphylobilin has been reported at the tetrapyrrole product of IsdG and IsdI (83).  
Staphylobilin loses a carbon atom during the heme degradation reaction like biliverdin although 
the cleavage site is different between staphylobilins and BVs (Fig. 1.1., 1.2., and 1.9.).  Based 
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on the structure of staphylobilin, two pathways of heme degrading mechanism are proposed for 
IsdG and IsdI (83).  One is β-meso-hydroxyheme intermediate is produced after the formation 
of ferric hydroperoxo heme and it then go through a verdoheme intermediate (Fig.1.12.).  
β-hydroxyverdoheme is formed through the one more hydroxylation and the porphyrin ring is 
opened to produce staphylobilin.  The other pathway is two times of hydroxylation are carried 
out to produce β,δ-dihydroxyheme intermediate before the formation of a verdoheme 
intermediate.  The β-hydroxyverdoheme is formed after the twice of hydroxylation, the 
porphyrin ring is opened to produce staphylobilin as same as the other pathway.  In both 
pathways, the porphyrin ring is opened from verdoheme intermediates although the pathways 
have a difference about the order of second hydroxylation, occurred before or after the 
formation of verdoheme intermediate.  If one of the proposed mechanisms is correct, IsdG and 
IsdI degrade heme, meaning how to open the porphyrin ring, basically as same as the canonical 
HOs.  It is also suggested CO is produced during the catalytic reaction, based on the proposed 
heme degrading mechanism.  The reaction mechanism, however, has proposed just from the 
structure of staphylobilins and any intermediates and even the production of CO have not been 
identified experimentally. 
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Figure 1.12. Proposed heme degrading mechanism of IsdG/IsdI producing staphylobilin 
in comparison to that of the canonical HO producing biliverdin. 
 
 
Heme degrading enzyme from Mycobacterium tuberculosis, mycobacterial heme utilization, 
degrader (MhuD), has been identified at a homologue of IsdG and IsdI and its crystal structure 
has been reported (82).  MhuD is composed of 105 amino acid residues with a total molecular 
weight of 11,184 and shares 46% and 43% sequence identity with IsdG and IsdI from S. aureus, 
respectively.  Additionally, MhuD conserves several key residues that have been reported to be 
crucial for heme degradation activity in IsdG from S. aureus (Asn7, Trp67, and His77) (Fig. 
1.11.).   
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The crystal structure of diheme-MhuD complex has been characterized and, interestingly, 
MhuD can bind up to two molecules of heme to its monomer (fig.1.13.) (82).  The 2:1 
heme-MhuD (diheme-MhuD) complex is, however, enzymatically inactive, and 1:1 
heme-MhuD (monoheme-MhuD) complex is actually active.  In diheme-MhuD complex, 21 
residues interact with the diheme molecule (heme-I and heme-II in Fig. 1.12.) and the iron atom 
of heme-I is pentacoordinated by His75.  In comparison to the crystal structures of N7A IsdG 
and wild-type IsdI, MhuD has two hemes per monomer but both IsdG and IsdI have only a 
heme per monomer.  The heme of IsdG and IsdI occupy a similar location as heme-II of MhuD 
although they are rotated approximately 90º about the axis normal to the tetrapyrrole ring with 
respect to heme-II in MhuD.  The discrepancy is due to subtle structural differences in MhuD, 
α-helix 2 is extended whereas the corresponding residues in the S. aureus proteins consist of two 
helices kicked at 45º angle (Fig.1.8. and 1.13.).  The other significant difference is the 
porphyrin rings of IsdG and IsdI are ruffled, but those of MhuD are flat.     
About enzymatic activity of MhuD, only heme degrading reaction has been observed (82), 
but the reaction mechanism and even the tetrapyrrole product have not been identified.   
 
 
Figure 1.13. Crystal structure (A) and its heme environment 
structure (B) of MhuD.  PDB code: 3HX9 
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1.7. Study of IsdG-type Heme Degrading Mechanism 
 
The proposed heme degrading mechanism of IsdG and IsdI is similar with canonical HOs.  
I expected, however, that it is possible that IsdG and IsdI have the distinct heme degrading 
mechanism comparing with the HOs because the tetrapyrrole products of IsdG and IsdI are not 
BVs.  In addition, the hemes bound to IsdG and IsdI are ruffled and it is reported the heme 
ruffling contributes markedly to IsdI enzyme activity.  The heme degrading mechanism of 
IsdG-type enzymes has not been reported until now and the fact is implying the study has not 
been carried out on S.aureus IsdG and IsdI.  Here, I study the active site structure and the 
product of MhuD, which is IsdG homologue, to predict the heme degradation mechanism of 
MhuD and IsdG/IsdI.  
  In Chapter II, the active site structure of ferric monoheme-MhuD is examined by electron 
paramagnetic resonance (EPR) study and resonance Raman study.  It is essential to determine 
the active site structure of monoheme-MhuD complex because only the crystal structure of 
diheme-MhuD complex, which is enzymatically inactive, has been characterized.  The results 
indicate that the active site of ferric monoheme-MhuD is further different from that of HO but 
may be similar to that of IsdG and IsdI. 
  In Chapter III, the active site of ferrous monoheme-MhuD is examined by EPR and resonance 
Raman study and the further investigation of the active site of ferric from is carried out by 
mutagenesis techniques.  The results strongly suggest that the active site structure of 
monoheme-MhuD is very similar to that of IsdG/IsdI.  Especially, the heme distortion was 
tested by the measurement of CN bound ferric monoheme-MhuD and it indicates the heme is 
ruffled.  Product analysis of MhuD heme degradation indicates a novel chromophore termed 
“mycobilin” and the MhuD catalysis does not release CO.  Based on the results, a unique 
mechanism for MhuD-mediated heme degradation is predicted. 
  In Chapter IV, it is demonstrated that CO is not major product of IsdG and IsdI enzymatic 
activities.  The result clearly reveals that both IsdG and IsdI degrade heme by an unusual 
mechanism distinct from the well-characterized HO mechanism as MhuD.  It concludes that 
heme ruffling is critical for the drastic mechanistic change for MhuD and IsdG/IsdI. 
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Chapter II 
Unique Catalytic Site of Active Form MhuD  
Shown by Resonance Raman and Electron Paramagnetic 
Resonance Spectroscopy 
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2.1. Introduction 
 
The active site structure, which is the site of binding heme, is very important to know the 
catalytic reactions of heme degrading mechanisms because all of them are self-oxidized to 
degrade heme (1-4).  The crystal structure of heme-IsdI complex has been characterized and it 
shows heme biding motif and its striking feature, heme ruffling (5).  The structure of N7A 
IsdG has been also characterized and it kept the features observed in heme-IsdI complex 
although N7A IsdG lacks its enzymatic activity (6).  About MhuD, the crystal structure of 
diheme-MhuD complex has been characterized but it does not provide useful information very 
much because the complex is enzymatically inactive (7).  In addition, its heme binding motif is 
different from IsdG and IsdI, which do not bind two molecules of heme per a monomer, and its 
hemes are not ruffled like observed in IsdG and IsdI.  Structural characterization of 
monoheme-MhuD complex, which is enzymatically active form, is very important to reveal its 
heme degrading mechanism.  Crystallization of monoheme-MhuD complex, however, seems 
difficult in fact its structure has not been reported. I employed resonance Raman spectroscopy 
and electron paramagnetic resonance (EPR) spectroscopy to examine the active site structure of 
monoheme-MhuD complex. Resonance Raman spectroscopy shows the vibrational frequencies 
which are responsive to important aspects of porphyrin geometry and electronic structure (8).  
I expected, therefore, that MhuD and IsdG/IsdI show some unique features on resonance Raman 
spectra if their hemes are ruffled.  EPR spectroscopy is commonly used to know the 
environments of heme iron including its atomic valence, symmetric property of porphyrin ring, 
and its electronic states with the ligands (9).   
In this study, these spectroscopic studies carried on the ferric monoheme-MhuD complex to 
examine its active site environment.  The results suggested that the active site of ferric 
monoheme-MhuD is further different from that of HO but is similar to that of IsdG and IsdI. 
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2.2. Experimental Procedures 
 
2.2.1. Expression and purification of apo MhuD 
The construction of the expression vectors for MhuD is described elsewhere.  A 100 ml 
inoculum in LB medium containing 100 μg/ml ampicillin was prepared overnight with a colony 
of E.coli BL21-GOLD (DE3) cells transformed with pET-22b-Rv3592.  500 ml cultures were 
inoculated with 10 ml of the prepared inocula and grown in LB medium containing 100 μg/ml 
ampicillin at 37ºC until OD600 reached 0.8, and the protein expression was induced by 1 mM 
isopropyl-β-D-thiogalactoside.  The cells were harvested after 8 hr by centrifugation at 3000 
rpm for 20 min and then washed with resuspension buffer (20 mM HEPES, pH 7.8, and 350 
mM NaCl).  The cells were stored at −80ºC until use.  The cells were sonicated (TOMY 
UD-201) on ice in resuspension buffer containing 1 mM PMSF, 0.1 mg/ml hen egg lysozyme, 
and 50 μg/ml DNAse.  The suspension was centrifuged (HITACHI himac CP 100MX) at 
35,000 rpm for 30 min.  The resulting supernatant was loaded onto a Ni
2+
-charged HisTrap 
column (5 ml) equilibrated with 50 mM Tris, pH 7.4, 350 mM NaCl.  Fractions eluted at 50 
mM imidazole were collected and concentrated (Amicon, 5 kDa molecular mass cutoff) to 2 ml.  
The protein was further purified on a Superdex 75 gel-filtration column (330 ml) equilibrated 
with 20 mM Tris-HCl, pH 8.0, and 10 mM NaCl.  Fractions eluted 150 to 170 ml was loaded 
onto an ion-exchange column (HiTrap Q HP 5 ml) equilibrated with 20 mM Tris-HCl and 10 
mM NaCl.  Fractions eluted at 50 mM NaCl concentrated to 1 mM and stored at −80ºC until 
use.  
 
 
2.2.2. Reconstitution of apo-MhuD with heme 
A 2.0 mM hemin solution was prepared in 40 mM NaOH and 80 mM KH2PO4.  To 
reconstitute monoheme-MhuD complex, 0.1 mM apo-MhuD was mixed with 2.0 mM hemin at 
1 : 1.2 molar ration and stored at 4ºC for 12 h with stirring.  The excess hemin was removed 
with DEAE column equilibrated with 0.1 mM potassium phosphate buffer pH 7.0 and 350 mM 
NaCl. 
 
 
2.2.3. Electron paramagnetic resonance (EPR) 
EPR spectra were obtained by a Bruker ESP-380 spectrometer operating at 9.53 GHz.  An 
Oxford liquid helium flow cryostat was used for cryogenic measurements.  The microwave 
frequency was monitored by a frequency counter (Anritsu MF241213), and the magnetic flux 
density was determined by a gauss meter (Bruker ESP-380 M).  The buffer were KPi pH 6.0, 
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7.0, Tris-HCl pH 8.0, and glycine pH 9.0.  
 
 
2.2.4. Resonance Raman spectra measurements for ferric monoheme-MhuD complex 
Resonance Raman spectra were obtained by using the following laser excitation: 405 nm 
laser (CrystalLaser LC DL405-015-S).  The scattered light at 90º was dispersed with a single 
polychrometer (Chromex 250is) and detected by a cooled CCD detector (ROPER SCIENTIFIC 
CCD-1340/400-EM).  The laser power on the sample was approximately 11 mW and the 
accumulation time was 10 min.  The sample cell was rotated at approximately 1000 rpm.   
The Raman shifts were calibrated with indene. 
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2.3. Results 
 
2.3.1 Heme titration of MhuD 
The heme titration was carried out to reconstitute monoheme-MhuD complex.  To 
reconstitute ml order monoheme-MhuD complex, 2.0 mM hemin was added to 100 μM MhuD 
at 1.2 : 1.0 molar ration calculated from the result of the heme titration (Fig. 2.1.).  After an 
overnight incubation, the excess hemin was removed by ion exchange column.  To confirm the 
prepared heme-MhuD complex composed at 1:1 molar ration, the concentrations of heme and 
MhuD in the complex were checked by hemochromogen method and Bradford method, 
respectively.  The results showed the concentrations of heme and MhuD were 1.13 mM and 
1.25 mM, respectively, confirming 0.9 : 1 molar ratio.  Additionally, apo-MhuD was mixed 
with heme at 1:2 molar ration or at 1:4 molar ration, which reconstitute condition was reported 
previously (7).  Then, the mixtures were incubated for overnight and applied to Superdex 75 
gel-filtration column, resulting the heme-MhuD complexes passed through the column were 
almost 1:1 ratio.  The results indicate that second heme binding to MhuD is very weak, 
especially compared with the first heme. 
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Figure 2.1. (A) Absorption spectra of heme-MhuD complex , 
(B) difference absorption spectra between heme-MhuD 
complex and added free hemin, and (C) the change in 
absorbance at 420 nm versus heme concentration against 
protein concentration.  The spectrum adding hemin to 
MhuD at 1:1 molar ratio (red line) and at 2:1 molar ratio 
(green line). 
 
 
 
 
 
1.0
0.8
0.6
0.4
0.2
0.0
A
b
s
o
rb
a
n
c
e
 (
A
U
)
700600500400300
Wavelength (nm)
A.
0.25
0.20
0.15
0.10
0.05
0.00
-0.05
A
b
s
o
rb
a
n
c
e
 D
if
fr
e
n
c
e
700600500400300
Wavelength (nm)
B.
0.25
0.20
0.15
0.10
0.05
0.00

A
b
s
.(
4
2
0
 n
m
)
43210
[heme]/[protein]
C.
33 
 
2.3.2. EPR study of ferric form of monoheme-MhuD complex 
Fig. 2.2. shows the pH-dependent changes in the EPR spectrum of the monoheme-MhuD 
complex between pH 6.0 and 9.0.  The complex at pH 6.0 exhibits an EPR spectrum of an 
axial symmetry typical of ferric high spin hemoproteins (g = 6.0 and 2.00).  At pH 7.0, it 
demonstrates both high and low spin species.  The low spin species has g values of 2.60, 2.21, 
1.81.  At pH 8.0, the high spin species decreased more and the low spin species increased more, 
finally, the high spin species almost disappeared and the spin state changed to low state at pH 
9.0.  It makes sure that a water molecule coordinates at the heme distal position because the 
spin state changes depending pH change.   
 
 
Figure 2.2. EPR spectra of ferric form of 
monoheme-MhuD complex at pH 6.0, 7.0, 8.0 
and 9.0. 
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2.3.3. Resonance Raman study of ferric form of monoheme-MhuD complex 
Fig. 2.3. shows the high frequency region of the resonance Raman spectra of the ferric 
monoheme-MhuD between pH 6.0 and 9.0.  It is well established that the lines in the high 
frequency region of the Raman spectrum of ferric hemoproteins are sensitive to the spin state of 
the central iron atom.  Specifically, ʋ 2 and ʋ 3 have distinct frequencies for pentacoordinated 
high spin (1570-1575 and 1490-1500 cm
-1
, respectively), hexacoordinated high spin (1560-1565 
and 1475-1485 cm
-1
, respectively), and hexacoordinated low spin (1580-1590 and 1500-1510 
cm
-1
, respectively) (10).  MhuD did not show clear line for ʋ 2 and ʋ 3. There are two 
possibilities to understand the phenomena.  One is several spin states are mixed at each pH, 
and the other one is the stretching mode of porphyrin ring is completely different from that of 
other hemoproteins.  If several spin states are mixed at the same pH, ʋ 2 at pH 7.0 can be 
analyzed 1561 cm
-1
 and 1582 cm
-1
exist together and they are assigned as hexacoordinated high 
spin and hexacoordinated low spin, respectively.  However, ʋ 3 cannot be assigned as any states 
and it is difficult to conclude the existence of several spin states at the same pH.   
 
 
Figure 2.3. Resonance Raman spectra of 
ferric form of monoheme-MhuD 
complex at pH 6.0, pH 7.0, pH 8.0, and 
pH 9.0. 
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2.4 Discussion 
 
The heme titration of MhuD shows that MhuD can bind upto two molecules of heme, 
which are also confirmed by the crystal structure of MhuD (7).  The second heme, however, 
binds very weakly and it unbinds from MhuD just though the gel filtration column.  The result 
indicates that the first heme binds much tighter than the second that by some rigid interactions 
with MhuD. 
The EPR results exhibits the heme iron in the ferric heme-enzyme complex is 
predominantly in hexacoordinate high spin and a low spin state under acidic and alkaline 
conditions, respectively.  About the low spin EPR spectrum of the alkaline form of 
monoheme-MhuD complex, the g-values are similar to those of HO (g1 = 2.67, g2 = 2.21, g3 = 
1.79) (11).  About electron configuration of IsdG-type enzymes, it is well discussed with ferric 
heme-IsdI complex (12).   The 
1
H NMR study for ferric heme-IsdI complex indicated it has a 
(dxz,dyz)
4
(dxy)
1
 component which has never been observed for heme bound protein because IsdI 
has severe distortion of heme but not other heme proteins.  The EPR spectrum of ferric 
heme-IsdI complex, however, exhibited the g-values (g1 = 2.61, g2 = 2.24, g3 = 1.78), at high pH 
and at 10 K, which were very similar to HO and indicated the electron configuration is 
(dxy)
2
(dxz,dyz)
3
.  It means the electron configurations of ferric heme-IsdI and HO are very 
similar at cryogenic temperatures and the electron configuration of ferric heme-IsdI is in 
dynamic exchange depending on the temperature.  The g-values of ferric monoheme-MhuD 
complex are similar to those of ferric heme-IsdI complex although their spectra patterns are 
slightly different each other.  Additionally, the EPR spectra of ferric heme-IsdG complex have 
been recently measured by Ph.D. student T. Nishiyama in our laboratory, Ikeda-Saito laboratory 
and its g-values are g1 = 2.59, g2 = 2.24, g3 = 1.80 (Fig. 2.4.).  The EPR spectra of ferric 
monoheme-MhuD complex are very similar to those of ferric heme-IsdG complex, including 
g-values, spectra patterns, and spectra changes depending on pH.  These results suggest that 
the active site structure of monoheme-MhuD complex is similar to those of IsdG and IsdI. In 
addition, it cannot be concluded the heme bound to MhuD is flat although the g-values of MhuD 
are similar to those of HO because IsdG and IsdI even show the similar g-values and the 
electron configurations possibly changed depending on the temperature.  It is no wonder that 
the heme of monoheme-MhuD complex is also ruffled although both hemes in the crystal 
structure of diheme-MhuD complex are flat. 
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Figure 2.4. EPR spectra of ferric form of 
heme-IsdG complex at pH 6.0, 7.0, 8.0 and 
9.0. Measured by T. Nishiyama  
 
 
The resonance Raman results shows unclear conclusion of the spin state under the 
conditions mentioned above although it could be observed in EPR.  The reason of the 
difference between ERP and resonance Raman results may be the temperature.  Heme proteins 
such as HO and myoglobin also have an acidic/alkaline transition at which they convert from 
hexacoordinate high spin to hexacoordinate low spin, although often these proteins display 
thermal mixture of spin states (11, 13, 14).  However, it is clear that water is bound to heme as 
sixth ligand because the spin state of MhuD changes depending on pH.  The resonance Raman 
spectra of heme-IsdG complex also show unclear spin states but they have a common feature, 
that almost peaks are very broad comparing with other heme proteins, with those of 
monoheme-MhuD (Fig.2.5.).  The EPR and resonance Raman results suggest that the active 
site structure of monoheme-MhuD is very similar to that of IsdG.  It means the heme of MhuD 
is probably ruffled like IsdG and the heme distortion may be related to the wired broad peak 
observed in both enzymes.  The board peak may be the mixture of planar and nonplanar states 
which has been observed in nickel (II)-reconstituted cytochrome c (15). Also, it reported as the 
effect of heme distortion that the frequencies of the structure-sensitive Raman lines decrease 
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nonlinearly with increasing ruffling angle (16).  The further analysis of resonance Raman 
spectra of MhuD and IsdG but the results does not show clear fittings for the broad peaks and an 
obvious line shifts to the low frequencies.   
In summary, this study suggests that the active site structure of ferric monoheme-MhuD 
complex is similar to those of IsdG and IsdI and the heme of MhuD is also ruffled like those of 
IsdG and IsdI, possibly. 
  
 
 
Figure 2.5. Resonance Raman spectra of ferric 
form of heme-IsdG complex at pH 6.0, pH 7.0, 
pH 8.0, and pH 9.0.  Measured by T. 
Nishiyama 
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3.1 Introduction 
 
Biological degradation of heme (iron-protoporphyrin IX, Fig. 3.1) plays a variety of crucial 
functions in living organisms (1, 2).  In mammals, an enzyme termed heme oxygenase (HO) 
catalyzes regiospecific conversion of heme into biliverdin IXα (Fig. 3.1), carbon monoxide 
(CO) and a free ferrous iron by three successive oxygenation reactions (3-6).  The HO-type 
enzymes have been also identified in some pathogenic bacteria where the heme degradation is 
employed to acquire iron, an essential nutrient required for the survival and infection, from host 
heme molecules to circumvent the low concentration of free extracellular iron (7-9).  Until 
recently, the HO family were thought to be the only heme degrading enzymes, however a novel 
family of enzymes with heme degrading capabilities has been identified in Staphylococcus 
aureus (10). S. aureus IsdG and IsdI are part of a heme-uptake pathway called the iron-regulated 
surface determinant system (Isd system) (11).  These two highly homologous proteins (78% 
sequence similarity) exhibit significant heme degrading activity (10).  The structures of the 
IsdG and IsdI enzymes are distinct from those of the HO-type enzymes as expected from their 
low sequence similarity (Figs. 3.2 A-C) (12).   
 
 
Figure 3.1. Structures of heme, biliverdin, and staphylobilins. 
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Figure 3.2. Heme environment structures of N7A IsdG 
(A), IsdI (B), rat HO-1 (C), and MhuD (D). PDB codes 
are: 2ZDO, 3QGP, 1N45, and 3HX9, respectively. 
 
One of the most striking structural features of the IsdG-type enzyme is the severe distortion 
of heme planarity, best described as ruffled, in contrast to planar heme observed bound to HO 
(12, 13).  Heme ruffling should have significant effects on the IsdG catalysis, because 
enzyme-bound heme activates molecular oxygen for self-decomposition as established for 
canonical HO reactions.  Actually, heme distortion is shown to contribute markedly to IsdI 
enzyme activity (14).  It is also reported that S. aureus IsdG and IsdI produce a non-biliverdin 
chromophore called staphylobilin (Fig. 3.1).  Staphylobilin is different from biliverdin with 
respect to the site of ring cleavage (β- or δ-meso cleavage rather than α-meso cleavage in 
biliverdin) and additional oxidation of the meso-carbon at the opposite side to have a δ- or 
β-meso carbonyl group (13).  These observations propose unique oxygen activation chemistry 
for IsdG; however, literally no mechanistic information is available thus far.   
Functional IsdG-family enzymes have been also identified in S. lugdunensis, Bacillus 
anthracis, Bradyrhizobium japonicum and Mycobacterium tuberculosis (15-18).  Among them, 
the M. tuberculosis enzyme, MhuD (mycobacterial heme utilization, degrader), has a unique 
structural feature in spite of relatively high sequence similarity with S. aureus IsdG and IsdI 
(46% and 43%, respectively).  MhuD but not other IsdG-type enzymes can accommodate two 
molecules of heme in its active site (heme-I and -II in Fig. 3.2.D), while the diheme complex of 
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MhuD is inactive (16).  An active form is the 1:1 complex of heme-MhuD (monoheme-MhuD) 
whose crystal structure is not available.   
Here, I have examined the active site structure of monoheme-MhuD by spectroscopic and 
mutagenesis techniques to show axial ligation of His75 and significant heme ruffling.  Product 
analysis of MhuD heme degradation indicates a novel chromophore termed “mycobilin”, which 
retains the α-meso carbon at the ring cleavage site as an aldehyde group.  As expected from the 
mycobilin structure the MhuD catalysis does not release CO.  To the best of my knowledge, 
this is the first report for enzymatic heme degradation without CO formation, and predicts a 
unique mechanism for MhuD-mediated heme degradation.   
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3.2 Experimental Procedures 
 
3.2.1 Materials 
18
O2, H2
18
O, Na
15
NO2 and NADPH were obtained from Spectra Gases, Taiyo Nippon Sanso, 
Cambridge Isotope Laboratories and Oriental Yeast, respectively.  Other chemicals obtained 
from Wako and Aldrich were used without further purification.  A H64L variant of sperm 
whale myoglobin, cytochrome P-450 reductase and rat HO-1 were prepared as described 
elsewhere (19-21).  Other proteins were purchased from Sigma (catalase and superoxide 
dismutase) and Wako (BSA).  
 
 
3.2.2 Resonance Raman spectra 
Ferrous monoheme-MhuD in 0.1 M HEPES pH 7.0 was prepared in an anaerobic glove 
box (MBraun, UNIlab).  A 100 μM solution of ferric monoheme-MhuD was sealed in a 
rotating cell after reduction by sodium dithionite (22).  The CO-bound forms were prepared by 
injecting either 
12
CO or 
13
CO gas into the sample cell.  Resonance Raman spectra were 
obtained by excitation using the 442 nm line of He-Cd laser (Kimmon, IK5651R-G) or the 405 
nm line of a solid-state laser (CrystaLaser, LC DL405) for ferrous and ferrous-CO MhuD, 
respectively.  The scattered light at 90º was dispersed with a single polychrometer (Chromex 
250is or Spex 500M) and detected by a cooled CCD detector (Roper Scientific 
CCD-1340/400-EM or Spex Spectrum One).  The laser power on the sample was 
approximately 13 or 3 mW with the accumulation time of 16 or 25 min for ferrous and 
ferrous-CO MhuD, respectively.  The sample cell was rotated at approximately 1,000 rpm, and 
the Raman shifts were calibrated with indene. 
 
 
3.2.3.EPR spectra 
Ferrous NO-bound monoheme-MhuD in 0.1 M HEPES, pH 7.0 was prepared in the UNIlab 
glove box by reducing a 1 mM solution of MhuD by sodium dithionite in the presence of 1 mM 
Na
15
NO2 (23).  EPR spectra were obtained by a Bruker ESP-380 spectrometer in the CW mode 
operating at 9.53 GHz.  An Oxford liquid helium flow cryostat was used for cryogenic 
measurements.  The microwave frequency was monitored by a frequency counter (Anritsu 
MF241213), and the magnetic flux density was determined by a gauss meter (Bruker ER-035 
M). 
 
 
46 
 
3.2.4. Heme degradation 
Heme degradation was performed at 37°C in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl.  
The reaction solution typically contained 15 µM monoheme-MhuD, 90 µM NADPH, 3 mM 
desferal, 0.25 μM CPR, 50 U/ml superoxide dismutase, 250 U/ml catalase, and 20 μM BSA.  
Absorption spectral change during the reaction was observed by an Agilent 8453 
spectrophotometer.  A saturated solution of guanidine hydrochloride (~8 M) was added to the 
reaction mixture of the heme degradation (1:2 ratio) for efficient extraction of pigments from 
the proteins.  Solid phase extraction of the reaction products was performed with Supelclean 
LC-18 columns (Supelco).  The sample bound to the column was washed by 20% 
methanol/80% water (v/v) and was eluted with methanol.  The effluents were analyzed on a 
Shimadzu LC-10 HPLC system equipped with a Tosoh ODS-80Tm reverse phase column (4.6 × 
150 mm) using a linear gradient from 50% methanol/50% 0.1 M ammonium acetate (v/v) to 
80% methanol (v/v) over 60 min at a flow rate of 0.5 mL/min.  The eluate was monitored 
using a Shimadzu photodiode array detector (SPD-M20A).  ESI-MS spectra in positive ion 
mode were measured on a Bruker micrOTOF-Q-II mass spectrometer.  Data acquisition and 
analyses were performed using the micrOTOFcontrol software, and the instrument was 
calibrated with sodium formate.  Measurements by direct infusion at 3 µL/min were carried out 
with following optimized settings: end plate offset, –500 V; capillary, –4500 V; nebulizer gas, 
0.4 bar; dry gas, 4.0 L/min; dry gas temperature, 180°C.  LC-MS was conducted using an 
Agilent 1260 HPLC system with higher nebulizer gas pressure (1.6 bar) and a dry gas flow rate 
(8.0 L/min).  LC separation with an Agilent Extend-C18 reverse phase column (2.1 × 150 mm) 
was performed using a linear gradient from 50% methanol/50% 10 mM ammonium acetate 
(v/v) to 65% methanol (v/v) over 10 min at a flow rate of 0.2 mL/min.  Labeling experiments 
with 
18
O2 were carried out in the glove box by injecting 
18
O2 to anaerobic enzyme solutions.  
Presence of water-exchangeable oxygen was examined by incubating purified mycobilins in 
H2
18
O. 
 
 
3.2.5. Detection of CO produced by heme degradation 
A sealed cuvette was filled with the reaction solution for MhuD or rat HO-1.  After the 
heme degradation reaction, all the contents were reduced by injection of 1 mM sodium 
dithionite to record the baseline.  Ferrous H64L Mb was added to trap CO in the reaction 
mixture, and then, the absorption spectrum of the Mb mutant was measured.  The same 
experiment was also performed before the heme degradation in order to obtain the Mb spectrum 
without CO.  Subtraction of these two spectra gave a difference spectrum of H64L Mb caused 
by generation of CO-bound H64L Mb so as to quantitate the amount of CO generated by the 
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enzymatic reactions.  
 
 
3.2.6. Large scale preparation of mycobilins and NMR spectra 
Large scale preparation of mycobilins was carried out in 50 mM MES buffer, pH 6.0.  The 
reaction mixture contained 50 µM monoheme-MhuD, 290 U/L catalase, 2.5 mM deferoxamine 
mesylate and 25 mM sodium ascorbate.  After 45 min incubation at 37°C, the heme 
degradation was terminated by adding HCl.  The crude sample obtained by the CH2Cl2 
extraction was pre-purified on a reverse phase TLC plate (Merck RP-18) running with methanol.  
Recovery of a purple band was followed by purification with the Shimadzu HPLC equipped 
with an FRC-10A fraction collector.  Each of the isolated products was dried up and 
re-dissolved in methanol-d4 (Merck, 99.8 atom % 
2
H).  NMR spectra of the purified 
mycobilins were measured at 27°C using a Bruker Avance III 600 spectrometer with a 
CryoProbe ATM.  Chemical shifts were referenced internally to methanol-d4.  One 
dimensional spectra were obtained using a water presaturation method (pulse sequence zgpr).  
Two dimensional spectra including COSY, NOESY, HSQC and HMBC were measured using 
standard methods (cosygpppgf, noesyphpr, hsqcetgpsisp2.2 and hmbcgplndprqf) provided by 
TopSpin software (Bruker).  A mixing time for NOESY was set to 0.8 ms.   
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3.3. Results 
 
3.3.1. Active site structure 
The active site structural characteristics of monoheme-MhuD were examined by 
spectroscopic measurements to assess its structural similarity in heme coordination and ruffling 
to IsdG and IsdI.  Resonance Raman spectra of the CO-bound ferrous monoheme complexes 
are shown in Fig. 3.3.  In the high frequency region, an isotope sensitive signal is seen at 1928 
cm
–1
 for the 
12
C
16
O-bound form (1883 cm
–1
 for the 
13
C
16
O complex) that is assignable as the 
C–O stretching mode.  CO isotope sensitive lines assignable to the Fe–C stretching and FeCO 
bending modes are respectively observed at 527 and 588 cm
–1
 (523 and 567 cm
–1
 for the 
13
C
16
O 
complex) in the low frequency region.  The frequencies of the Fe–CO and C–O stretching 
modes normally show an inverse correlation which is sensitive to nature of the heme axial 
ligand (24).  The data point for monoheme-MhuD is close to a correlation line for hemes with 
an imidazole ligand (Fig. 3.3.B), suggesting axial coordination of His.  Further support for the 
His ligation was provided by the resonance Raman spectrum of ferrous monoheme-MhuD (Fig. 
3.3.C).  A prominent signal at 218 cm
–1
 can be assigned as the Fe–His stretching mode, which 
is normally observed at 200-220 cm
–1
 or at around 240 cm
–1
 for neutral imidazole and anionic 
imidazolate ligands, respectively (25).  The axial His of MhuD has neutral imidazole character 
as observed for the axial His ligands in classical HO enzymes (22).   
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Figure 3.3. Resonance Raman analysis of monoheme-MhuD complex in 0.1 M 
HEPES, pH7.0. (A) resonance Raman spectra of ferrous CO-bound 
monoheme-MhuD complex prepared with 
12
C
16
O (top) and 
13
C
16
O (middle).  
The bottom trace is a difference spectrum (
2
C
16
O ‒  13C16O).  The spectra were 
obtained with 405 nm excitation and a laser power of ~3 milliwatts. (B) a 
correlation plot for the Fe‒ C and C‒ O frequencies of the CO‒ bound ferrous 
monoheme-MhuD complex.  Data points are for His-ligated heme proteins 
(circles), and Cys-ligated heme proteins (squares), and MhuD (filled circle). (C) 
resonance Raman spectrum for the ferrous heme-MhuD complex without 
exogenous ligands (442 nm excitation with a lasor power of ~13 milliwatts). 
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The His coordination was further examined by EPR.  As shown in Fig. 3.4.A, the nitric 
oxide (
15
NO) complex of ferrous monoheme-MhuD exhibits an EPR spectrum typical for a 
hexacoordinated NO hemoprotein with a rhombic symmetry (g1 = 2.076, g2 = 2.001, g3 = 1.963).  
The spectrum demonstrates that the doublet with a coupling constant of 3.1 mT is associated 
with the g2 signal due to the 
15
N nucleus (I = 1/2) of bound 
15
NO.  The triplet splitting with a 
coupling constant of 0.65 mT is associated with the 
14
N nucleus (I = 1) of the axial ligand trans 
to bound NO (26).  This firmly establishes that the axial heme ligand of the monoheme 
complex is a nitrogenous base, likely an imidazole group of His.  An Ala substitution of His75, 
an axial ligand of heme-II in the diheme-MhuD structure (Fig. 3.2.D), resulted in significant 
changes in light absorption spectrum of the monoheme complex (Fig. 3.4.B).  The EPR 
spectrum of the NO-heme complex is also changed to that of typical pentacoordinated hemes, 
consistent with a loss of the axial His (Fig. 3.4.A).  These results indicate that heme in the 
active MhuD form is coordinated by His75, as observed for His77 and His76 ligations in IsdG 
and IsdI, respectively (Figs. 3.2.A and B).   
While in diheme-MhuD structure both heme molecules are essentially flat (Fig. 3.2.D), 
monoheme-MhuD is suggested to have ruffled heme.  The most commonly observed 
spectroscopic consequence of porphyrin nonplanarity is a red shift in the π–π* absorption bands 
in the UV–visible spectrum (27).  Absorption peaks, especially a visible peak, of the 
cyanide-bound ferric-IsdG is unusually red-shifted to 558 nm, while those of rat HO-1 and 
myoglobin (Mb) are observed at 536 and 540 nm, respectively (28-30).  The CN-bound 
monoheme-MhuD also exhibited a significant red-shift of the visible peak to 553 nm (Fig. 
3.4.B), suggesting a highly distorted porphyrin ring.   
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Figure 3.4. EPR and absorption spectra of monoheme-MhuD complexes in 0.1 
M HEPES, pH7.0. (A) EPR spectra of the 15NO-bound ferrous 
monoheme-MhuD complexes of wild type (top) and the H75A variant (bottom).  
The spectra were recorded at 25 K with a microwave power of 0.2 milliwatt 
with 0.1 millitesla field modulation at 100 kHz. (B) absorption spectra of the 
ferric monoheme-MhuD complexes of wild type (solid line), the H75A variant 
(dashed line), and the ferric CN-bound complex of wild type (dotted line) at 
20ºC. 
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3.3.2. Heme degradation to a novel chromophore 
As reported earlier (16), addition of NADPH and cytochrome P450 reductase (CPR) to 
monoheme-MhuD results in a loss of the Soret absorption around 400 nm, indicating 
progression of heme breakdown (Fig. 3.5.A).  A concomitant increase in the absorption around 
550 nm suggests accumulation of heme-derived pigment(s).  The His75Ala variant of MhuD is 
inactive, as only limited decrease of the Soret absorption is observed (Fig. 3.5.B) (16). Fig. 
3.5.B also shows that replacement of an Asn residue close to the heme-I site (Asn7) by Ala 
diminishes enzymatic activity of MhuD.  Since these two residues (His77 and Asn7 in IsdG) 
have also been shown to be indispensable for the IsdG catalysis (31), this would suggest that the 
active site structure of monoheme-MhuD is similar to that of IsdG.   
HPLC analysis of the MhuD reaction product reveals two main peaks having similar 
absorption spectra while biliverdin IX elutes as a single peak at a different retention time (Figs. 
3.5.C and D).  In the high resolution ESI-MS analysis (positive mode), the first and second 
peaks give essentially the same mass numbers, 611.2500 and 611.2505, respectively (Fig. 3.6.A), 
suggesting that they are regioisomers with a molecular formula of C34H34N4O7+H
+
 (calculated 
m/z: 611.2506).  Since these molecular masses do not match with any known heme catabolites 
(Table 1), the MhuD products having purple colors are identified as novel heme catabolites (Fig. 
3.5.D).  I designate these novel catabolites as “mycobilin”; mycobilin-a and mycobilin-b for 
the pigments eluted at 40 and 45 min, respectively.   
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Figure 3.5. Heme degradation by MhuD in the presence of NADPH and CPR.  (A) 
Absorption spectral change recorded before (solid) and 10, 20, 30 (dotted), and 50 
(red) min after initiation of the reaction by adding CPR.  Directions of absorbance 
changes are indicated by arrows.  (B) Normalized decrease of Soret absorbance 
upon the heme degradation by wild type, H75A and N7A monoheme-MhuD (black, 
blue and red, respectively).  (C) HPLC chromatograms of the MhuD reaction 
products (red) and authentic biliverdin (blue) monitored at 360 nm.  The two purple 
pigments eluted at 40 and 45 min are designated mycobilin-a and mycobilin-b, 
respectively.  (D) Absorption spectra of mycobilins-a, -b and biliverdin (red, blue 
and black lines, respectively).  Inset shows colors of the isolated solutions of 
mycobilin-a (left) and mycobilin-b (right).  (E) CO quantification in the heme 
degradation.  Spectral changes of ferrous H64L Mb were calculated from the 
spectra taken before and after the heme degradation by 5 µM heme complexes of rat 
HO-1 (blue) and MhuD (black), respectively.  The red line represents difference 
spectrum of 5 µM ferrous H64L Mb upon the saturation with CO. 
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Figure 3.6. ESI-MS spectra of mycobilins.  (A) High resolution mass spectra for 
mycobilin-a (top) and mycobilin-b (bottom) prepared in air-saturated buffer.  (B) 
and (C) Mycobilin-a and mycobilin-b produced under 
18
O2 atmosphere (top), 
incubated with H2
18
O (middle) and produced under 
18
O2 followed by incubation 
with H2
18
O (bottom), respectively. 
 
 
Table 3.1.  Comparison of mycobilin with heme, biliverdin, bilirubin, and staphylobilin 
 chemical formula calculated mass
*
 
Heme FeC34H32N4O4 616.1773 
Biliverdin C33H34N4O6 583.2557 
Bilirubin C33H36N4O6 585.2713 
Staphylobilin C33H34N4O7 599.6550 
Mycobilin C34H34N4O7 611.2506 
*
 Molecular masses for compounds other than heme were calculated for their protonated forms. 
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3.3.3. Implications from the molecular formula of mycobilin 
The molecular formula of mycobilins in comparison with those of heme, staphylobilins, 
biliverdin and its reduced form, bilirubin, provides two important implications (Table 3.1.).  
The first suggested from the number of oxygen atoms is the incorporation of three oxygen atoms 
during MhuD catalysis.  The three oxygen incorporation has been shown for staphylobilin 
formation in contrast to the two oxygen addition in biliverdin production (Fig. 3.1.).  Although 
heme degradation by MhuD in the presence of 
18
O2 resulted in a mass increase of four, 
indicating addition of only two oxygen atoms, one more oxygen atom was found to be 
exchangeable with a water oxygen atom (Figs. 3.6.B and C).  The molecular mass of 
mycobilin was increased to 617.25, when mycobilin produced under 
18
O2 was incubated in 
H2
18
O.  These results suggest that mycobilin has a similar structure to staphylobilin however it 
contains a unique functional group with an exchangeable oxygen such as an aldehyde group.   
The second implication from the number of carbon atoms is that there is no formation of 
CO by the MhuD reaction.  The heme degradation by canonical HO results in the decrease in 
the number of carbon atoms from 34 to 33 due to the liberation of one meso carbon atom as CO 
(Table 3.1.).  Similar decrease is also observed for the S. aureus enzymes; however, mycobilin 
retains 34 carbon atoms, leading to the proposal that heme degradation by MhuD does not 
release CO (Table 3.1.).  The enzymatic CO release was assessed by using a H64L variant of 
Mb which has an extremely high CO affinity (19).  Fig. 3.5.E shows the Soret region 
difference spectra of ferrous H64L Mb induced by CO generated in the single turnover heme 
degradation.  The reaction solution for rat HO-1 exhibited a significant difference spectrum 
whose intensity accounts for nearly stoichiometric formation of CO.  In contrast, essentially no 
spectral change was observed for MhuD, indicating the absence of CO in the reaction solution 
of MhuD.  This is the first instance of enzymatic heme degradation without CO generation. 
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3.3.4. Determination of mycobilin structure 
1
H-NMR spectra reveal that mycobilin isomers retain all the substituents on the porphyrin 
ring (four methyl, two vinyl, and two propionate groups) (Table 3.2., Figs. 3.7.A and 3.8.A). As 
in staphylobilin, only two meso-protons were observed for the mycobilin isomers, indicating 
heme cleavage at one meso position and oxidative modification at another meso carbon.  A 
striking feature, that differentiates mycobilin from staphylobilin, is additional signals at 9.58 
ppm (Table 3.2.).  Each of these signals exhibits a correlation with a 
13
C signal at ~181 ppm in 
the HSQC spectra (Table 3.2., Figs. 3.7.D and 3.8.D), and are assigned as aldehyde protons.  A 
NOESY experiment on mycobilin-a successfully determined its structure (Figs. 3.9.A and C).  
The two meso protons of mycobilin-a are assigned as γ- and δ-meso protons based on their 
correlations with four methylene groups of the propionates (C8 and C12) or two methyl groups 
(C13 and C17), respectively.  The aldehyde group should be at the C1 position considering its 
correlation with the C2 methyl.  Furthermore, an HMBC correlation from a vinyl proton at 
C18 suggests a carbonyl moiety at C19 (Table 3.2. and supplemental Fig. 3.7.E), leading to a 
clear conclusion that the ring cleavage occurs at the α-meso position.  The remaining C5 
carbon lacks any proton signals and any correlations from neighboring protons, consistent with 
a bridging carbonyl structure as also expected from the MS analysis.  All the COSY, NOESY 
and HMBC correlations observed for mycobilin-a are depicted in supplemental Figs. 3.10.A and 
B.  A very similar structure was revealed for mycobilin-b (Fig. 3.8., 3.9.B, and 3.10.C); the 
ring cleavage at the α-meso position, an aldehyde group at C19 and oxidative modification at 
δ-meso position.  Mycobilin-b is a regioisomer of mycobilin-a whose aldehyde and carbonyl 
groups are superimposable with each other by rotating the heme plane about the α-γ axis.   
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Figure 3.7.  NMR spectra of mycobilin-a. (A) 1D 
1
H-NMR spectrum indicates mycobilin-a 
contains four CH3 groups, four CH2 groups, two sets of vinyl groups, two meso protons and one 
aldehyde proton.  Solvent peaks are marked with asterisks. 
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Figure 3.7.  NMR spectra of mycobilin-a. (continued) (B) COSY spectrum allows grouping of 
four CH2 and six vinyl signals into two propionates and two vinyl groups, respectively.  (C) 
NOESY spectrum determines relative arrangement of the substituents to assign the signals.  
The aldehyde proton exhibits a correlation with a 2-CH3 group which further shows a 
correlation with a 3-vinyl group.  These three signals are isolated from other signals consistent 
with the oxidative modification at the β-meso carbon.  
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Figure 3.7.  NMR spectra of mycobilin-a. (continued) (D) HSQC spectrum confirms the 
assignment of the 9.6 ppm signal as an aldehyde proton.  (E) HMBC spectrum is also 
consistent with the mycobilin-a structure.  Especially, the 18-vinyl exhibits a correlation with a 
carbonyl carbon, consistent with the ring cleavage at the α-meso position.  
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Figure 3.8.  NMR spectra of mycobilin-b. (A) 1D 
1
H-NMR spectrum indicates mycobilin-b 
contains four CH3 groups, four CH2 groups, two sets of vinyl groups, two meso protons and one 
aldehyde proton.  Solvent peaks are marked with asterisks.  (B) COSY spectrum allows 
grouping of four CH2 and six vinyl signals into two propionates and two vinyl groups, 
respectively.   
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Figure 3.8.  NMR spectra of mycobilin-b. (continued) (C) NOESY spectrum determines 
relative arrangement of the substituents to assign the signals.  The aldehyde proton exhibits a 
correlation with a 18-vinyl group which further shows a correlation with a 17-CH3 group.  
These three signals are isolated from other signals consistent with the oxidative modification at 
the δ-meso carbon.  (D) HSQC spectrum confirms the assignment of the 9.6 ppm signal as an 
aldehyde proton.   
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Figure 3.9 
1
H-NMR spectra and structures of mycobilins.  (A) and (B) represent molecular 
structures of mycobilin-a and mycobilin-b, respectively.  (C) NOESY spectra of mycobilin-a. 
 
 
 
 
 
Figure 3.10.  Two dimensional NMR correlations of mycobilins.  (A) COSY and NOESY 
correlations for mycobilin-a (blue and red arrows, respectively), (B) HMBC correlations for 
mycobilin-a (green arrows), and (C) COSY and NOESY correlations for mycobilin-b (blue and 
red arrows, respectively) 
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Table 3.2. 
1
H NMR data of mycobilins 
 mycobilin-a   mycobilin-b 
 1H HSQC NOESY   1H HSQC NOESY 
13, CH3 2.12 9.7 2.95, 6.19  2, CH3 1.97 9.6 5.72, 5.73 
17, CH3 2.24 9.4 6.19, 6.64  7, CH3 2.08 9.4 2.95, 6.16 
2, CH3 2.27 10.8 5.17, 9.58  17, CH3 2.17 12.2 5.43 
7, CH3 2.32 10.5 2.49, 3.04  13, CH3 2.38 10.3 3.06 
12, CH2 2.49 38.1 2.32, 3.04  8, CH2 2.48 38.2 2.95, 7.21 
8, CH2 2.52 37.9 2.95  12, CH2 2.52 37.9 3.06, 7.21 
12, CH2 2.95 21.7 2.12, 2.52, 
7.18 
 8, CH2 2.95 21.5 2.08, 2.8, 7.21 
8, CH2 3.04 21.0 2.32, 2.49, 
7.18 
 12, CH2 3.06 20.8 2.38, 2.52, 7.21 
3, =CH2 
trans 
5.17 118.2 2.27  18, =CH2 cis 5.32 118.8 5.43, 6.86 
3, =CH2 cis 5.23 118.2 6.66  18, =CH2 trans 5.43 118.8 2.17, 5.32 
18, =CH2 5.53 122.0 6.28, 6.64  3, =CH2 5.72 123.0 1.97, 6.73 
15 6.19 100.3 2.12, 2.24  3, =CH2 5.73 123.0 1.97, 6.73 
18, =CH2 6.28 122.0 5.53, 6.64  5 6.16 100.0 2.08, 6.16 
18, –CH= 6.64 127.1 2.24, 5.53, 
6.28 
 3, –CH= 6.73 126.9 5.72, 5.73, 2.08 
3, –CH= 6.66 129.4 5.23  18, –CH= 6.86 128.4 5.32, 9.58 
10 7.18 117.2 2.95, 3.04  10 7.21 117.0 2.95, 3.06, 2.48, 
2.52 
1, CHO 9.58 181.6 2.27  19, CHO 9.58 181.4 6.86 
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3.4. DISCUSSION 
 
In this study, I have discovered that MhuD catalyzes the heme degradation by an 
unconventional mechanism that may be promoted by the unique heme environment of the M. 
tuberculosis enzyme.  The flexible active site of MhuD allows the unusual diheme binding 
with a more opened conformation compared to those of IsdG and IsdI (Fig. 3.2.) (16).  My 
spectroscopic data shows that His75 close to the heme-II binding site is the heme axial ligand in 
catalytically active monoheme-MhuD (Figs. 3.3. and 3.4.).  I also have found that Asn7 close 
to the heme-I site is indispensable for the catalytic activity of MhuD in spite of its large distance 
from the heme-II site (7.6 Å from the heme-II iron, Fig. 3.2.D).  These observations imply that 
monoheme-MhuD has a more compact conformation than its diheme complex, whereby heme is 
located at the heme-I site with His75 ligation.  The proximal helices containing the axial ligand 
(yellow in Figs. 3.2.A and B) are kinked in IsdG and IsdI to bring the proximal His closer to the 
distal Asn, while the extended proximal helix in MhuD (Fig. 3.2.D) appears to create a cavity 
that can accommodate the second heme.  In monoheme-MhuD, structural changes at the heme 
proximal side could allow heme binding at the heme-I site with His75 coordination.  The 
heme-I site is almost superimposable with the binding sites of ruffled hemes in IsdG and IsdI 
(Figs. 3.2. and 3.11.).  Furthermore, heme ruffling is suggested for monoheme-MhuD by its 
unusual red-shift of the visible absorption peak of ferric-CN MhuD.  On the basis of these 
findings, I conclude that the active site structure of monoheme-MhuD is similar to that of IsdG 
and IsdI (Fig. 3.2.).   
 
 
Figure 3.11.  Superimposed structures of heme complexes of IsdI (green) and 
MhuD (grey).  (A) Overall structures, (B) hemes in top view and (C) side view. 
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In spite of the structural similarity to IsdG and IsdI, MhuD produces a novel heme catabolite, 
mycobilin, which is distinct from biliverdin and staphylobilin.  Mycobilin retains the meso 
carbon atom at the ring cleavage site as the aldehyde group (Fig. 3.9.).  Consequently, CO is 
not released in the MhuD catalysis as corroborated by the CO trapping experiments using the 
Mb variant (Fig. 3.5.E).  This unprecedented heme degradation by MhuD must proceed by a 
unique reaction mechanism.  Although similar ring cleavage generating the aldehyde and 
carbonyl terminals is known for ring opening of pheide a in chlorophyll catabolism, this 
reaction proceeds through oxidation of metal-free pheide a by a non-heme iron monooxygenase 
(32).  This reaction mechanism is different from the self-oxygen activation at the central iron 
of hemes in MhuD and HO enzymes. 
In canonical HO catalysis, three successive oxygenations convert heme into biliverdin, and 
CO is generated at the second step, meso-hydroxyheme to verdoheme (Fig. 3.12.) (5, 6).  
Apparent absence of CO formation indicates that the MhuD catalysis does not involve 
verdoheme, which is the key intermediate of ring cleavage by HO.  Although the ring opening 
mechanism of verdoheme has been elucidated in HO enzymes (6, 33-35), essentially no 
mechanistic information is available for ring cleavage not via the verdoheme species.   
meso-Hydroxyheme has a radical character to promote the reaction with dioxygen (5).  As a 
consequence, the hydroxyheme conversion to verdoheme does not require assistance by the HO 
enzyme (36).  Thus, it is likely that MhuD drastically changes the nature of hydroxyheme not 
to afford verdoheme and CO (Fig. 3.12.).  The ruffling of hydroxyheme is suggested to 
modulate its reactivity through its large steric distortion and/or by changing its electronic 
configuration.  The latter on the ferric heme iron is proposed to increase susceptibility of the 
meso-carbon to oxidative attack (29).  This ruffling-mediated product change appears to 
contradict the staphylobilin formation in S. aureus IsdG and IsdI in which one meso carbon is 
postulated to be liberated as CO (13). However, CO release accompanied by staphylobilin 
formation has not been experimentally assessed for either S. aureus enzyme.  My recent study 
indicates that IsdG and IsdI produces CO but only as a minor product of the heme degradation, 
strongly supporting my proposal that the heme ruffling controls CO formation by biological 
heme degradation. 
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Figure 3.12. Possible reaction pathways of HO and MhuD.  meso-Hydroxyhemes 
including its complex with the HO enzyme are highly reactive with O2 to afford 
verdoheme with release of CO.  While the hydroxyheme formation is also postulated 
for MhuD catalysis, its reactivity appears to be drastically modified by the heme 
ruffling to cleave its macrocycle not through the verdoheme intermediate. 
 
MhuD shows distinct regioselectivity in ring cleavage and oxidative modification.  In 
staphylobilin, the macrocycle is cleaved either at β- or δ-meso position (Fig. 3.1.).  The meso 
carbon diagonal to the cleavage site is also oxidized to have a carbonyl group at the δ- or 
β-meso position.  This diagonal oxidation has been rationalized by heme ruffling, which places 
β- and δ-meso carbons proximal to a terminal oxygen atom of the putative iron-dioxygen 
reactive species (13).  In contrast, MhuD cleaves the macrocycle exclusively at the α-meso 
carbon (Fig. 3.9.).  This may be due to a different conformation of heme bound to MhuD 
compared to IsdG and IsdI, whereby heme is rotated about the heme normal.  The heme-I in 
diheme-MhuD is rotated approximately 90° compared to the heme in IsdI and the heme-II in 
diheme-MhuD (Figs. 3.2. and 3.11.).  The heme in active monoheme-MhuD is likely to be 
rotated as observed for heme-I in the diheme complex.  Ruffling of the rotated heme would 
elevate the α- and γ-meso carbon, consistent with the α-selective ring cleavage in 
monoheme-MhuD.  In contrast to IsdG, the ring oxidation by MhuD occurs either at the 
adjacent β- or δ-meso carbon but not at the diagonal γ-meso carbon (Fig. 3.9.).  Thus, the 
regioselectivity of MhuD cannot be explained solely by the proximity effect imposed by heme 
ruffling.  Distal residues may provide a steric barrier to the γ-meso carbon and/or direct the 
reactive iron-dioxygen species toward the α-meso carbon to be oxidized. 
Heme degradation in bacterial systems has been shown to be important for the iron 
acquisition from host heme (7-9).  Other biological functions have never been identified for 
these bacterial enzymes including HO- and IsdG-type enzymes.  This is in contrast to the 
mammalian HO system where CO is utilized as a physiological messenger molecule, and 
bilirubin, a reduced form of biliverdin, serves as a potent antioxidant (1, 2, 37).  No CO 
formation by MhuD could have biological significance for M. tuberculosis. The genetic 
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response of M. tuberculosis to hypoxia, NO and CO is controlled by the two-component sensory 
(Dos) system and results in activation of the dormancy regulon (38), where mycobacteria enter a 
non-replicating state.  The Dos system contains two sensor histidine kinases DosS and DosT 
(both of which have heme co-factor GAF domains that bind gaseous host molecules) and the 
cognate response regulator DosR (39).  When CO binds preferentially to DosS (40), it triggers 
the mycobacterial dormancy regulon (40, 41).  Furthermore, it has been demonstrated that host 
CO is produced by the upregulation of HO-1 in macrophages during mycobacterial infection 
(41).  Thus, one may speculate that M. tuberculosis and perhaps other pathogenic bacteria, 
have evolved a mechanism for heme degradation that does not generate CO so that it may adapt 
and respond to changes in the host immune status through CO sensing, and with respect to M. 
tuberculosis, so that it does not induce a latent state upon itself.  While possible functions of 
mycobilin as well as staphylobilin are yet to be examined, these product variations may be a 
major reason for a group of the bacterial species to prefer the IsdG-type enzyme over the 
HO-type enzyme for heme degradation.  In order to clarify the biological functions, more 
extensive product analysis is required for the IsdG-type enzymes.   
In summary, I have discovered that MhuD from M. tuberculosis catalyzes heme 
degradation without generating CO.  This finding indicates the presence of an alternative heme 
degradation pathway which is fundamentally distinct from that established for canonical HO.  
Elucidation of this novel mechanism of MhuD is crucial to understand functionality of the 
IsdG-type enzymes, and possibly, the relationship of this unique oxygen activation with heme 
ruffling.  Further studies will generalize the product variations between the IsdG- and HO-type 
enzymes. 
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Chapter IV 
Liberation of Formaldehyde Rather Than Carbon Monoxide by 
Heme Degradation of IsdG and IsdI 
*published in: Matsui, T., Nambu, S., Ono, Y., Goulding, C. W., Tsumoto, K., Ikeda-Saito, M. 
(2013) Heme Degradation by Staphylococcus aureus IsdG and IsdI Librates Formaldehyde 
Rather Than Carbon Monoxide, Biochemistry 52, 3025-3027. 
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4.1. Introduction 
 
Heme oxygenase (HO) is known to degrade heme into iron and biliverdin (BV) with the 
release of a meso carbon atom as carbon monoxide (CO) (Fig. 4.1.) (1-3).  IsdG and IsdI also 
consume oxygen molecules to degrade heme by self-oxidations although the crystal structures 
of IsdG and IsdI are distinct from those of canonical HOs and the hemes bound to IsdG and IsdI 
are ruffled (4, 5).  This heme ruffling is expected to significantly modulate the O2 activation 
chemistry on the heme molecule, and in fact, a novel tetrapyrrole, staphylobilin, with an 
additional oxidation at a meso carbon is produced (5).  The structure of staphylobilin makes 
sure that it releases meso-carbon and it was proposed that the carbon atom is released as CO by 
the basically same mechanism as HO.  The CO generation, however, has never observed 
experimentally in the heme degrading reaction of IsdG and IsdI. 
In Chapter 3, I showed that MhuD, an IsdG homologue from Mycobacterium tuberculosis, 
catalyzes heme degradation without generating CO (Fig. 4.1.).  The carbon atom at the site of 
ring cleavage is not released but retained as an aldehyde group, resulting in formation of a novel 
chromophore, mycobilin.  The unprecedented observation indicates a unique reaction 
mechanism of MhuD that is distinct from the well-understood mechanism of canonical HO.  I 
have attributed the drastic change is mechanism to the heme ruffling as observed in the S.aureus 
enzymes IsdG and IsdI heme-bound-structures.  If the prediction is, however, correct that 
MhuD does not release CO influenced by its ruffled heme, it is contradicted the report which 
IsdG and IsdI release CO although their hemes are ruffled.  Any experimental evidences are, 
however, lacked for the CO generation as mentioned above.   
In this study, I experimentally confirm IsdG and IsdI do not liberate CO in their catalytic 
reactions and my colleague determines the C1 products of S. aureus IsdG and IsdI for the first 
time.  
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Figure. 4.1. Heme degradation products of the HO- and IsdG-type enzymes 
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4.2. Experimental Procedures 
 
4.2.1. Expression and purification of S. aureus IsdG and IsdI 
cDNAs for IsdG and IsdI proteins with a stop codon were cloned into a NdeI-XhoI site of 
pET26 (Novagen).  E. coli BL21(DE3) harboring either pET26-IsdG or pET26-IsdI was grown 
at 37°C in LB medium containing 20 µg/ml kanamycin until OD600 reached 1.0 at which IPTG 
was added (final concentration: 0.5 mM).  The cells were grown for an additional 9 h at 37°C 
before being harvested by centrifugation and stored at –80°C until use.  The cell pellets were 
thawed and resuspended with 20 mM Tris, pH 8.0 containing 1 mM phenylmethylsulfonyl 
fluoride.  The cells then were sonicated (Tomy UD-201) until no longer viscous and 
centrifuged at 35k rpm for 30 m.  The resulting supernatant was subjected to fractionation by 
ammonium sulfate.  The precipitates formed at 40-80% saturation were dissolved and dialyzed 
into 20 mM Tris, pH 8.0.  The desalted solution was loaded on an anion-exchange column 
(Whatman DE52) equilibrated with 20 mM Tris, pH 8.0, and the target proteins were eluted by a 
linear gradient of 0 to 250 mM or 500 mM KCl for IsdG and IsdI, respectively.  Appropriate 
fractions were concentrated and gel-filtrated through a Superdex 75 column (GE health care) 
with 20 mM Tris-HCl pH 8.0, 10 mM NaCl.  Purified proteins were stored at –80°C until use. 
 
 
4.2.2. Reconstitution of heme-IsdG and IsdI complex  
To the solution of approximately 0.5 mM IsdG or IsdI in 20 mM Tris, pH 8.0 was added 
1.5 mole equivalents of 2 mM hemin chloride.  The overnight incubation at 4°C was followed 
by neutralization with 1/4 vol. of 1 M sodium phosphate, pH 7.0.  Excess hemin was removed 
by repetitive passage through a short DE52 column equilibrated with 0.2 M sodium phosphate, 
pH 7.0.  Extinction coefficients for the heme complexes of IsdG and IsdI were determined by a 
pyridine-hemochromogen method (ε411(IsdG) = 91 mM
–1
cm
–1
 and ε407(IsdI) = 81 mM
–1
cm
–1
 in 
0.1 M HEPES, pH 7.0 at 20°C. 
 
 
4.2.3. Heme Degradation and Tetrapyrrole Analysis 
Heme degradation was performed by adding 5 mM sodium ascorbate to 10 μM heme 
complexes of rat HO-1 (rHO-1), IsdG, and IsdI in 50 mM Tris, pH 7.5, 150 mM NaCl 
containing 1 μM catalase at 20ºC, while those for MhuD were conducted at 37 ºC with further 
supplementation of 3 mM desferal and 50 U/ml superoxide dismutase to improve mycobilin 
yields.  Absorption spectral change during the reaction was observed by Agilent 8453 
spectrometer.  Solid phase extraction of colored tetrapyrroles were performed by using a 
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LC-18 SPE column (Supelco) as reported in Part II.  The effluents were analyzed on a 
Shimadzu LC-10 HPLC system equipped with a Tosoh ODS-80Tm reverse phase column (4.6 x 
150 mm) using a linear gradient from 55% methanol/45% 0.1 M ammonium acetate (v/v) to 
65% methanol (v/v) over 20 min at a flow rate of 1.0 mL/min.  LC-ESI-MS analysis was 
performed on a micrOTOF-Q II mass spectrometer (Bruker Daltonics) equipped with an Agilent 
1260 HPLC system. 
 
 
4.2.4. Detection of CO Produced by IsdG and IsdI Heme Degradation 
A sealed cuvette was filled with the reaction solution for IsdG or IsdI.  After the heme 
degradation reaction, all the contents were reduced by injection of 1 mM sodium dithionite to 
record the baseline.  Ferrous H64L Mb was added to trap CO in the reaction mixture, and then, 
the absorption spectrum of the Mb mutant was measured.  The same experiment was also 
performed before the heme degradation in order to obtain the Mb spectrum without CO.  
Subtraction of these two spectra gave a difference spectrum of H64L Mb caused by generation 
of CO-bound H64L Mb so as to quantitate the amount of CO generated by the enzymatic 
reactions. 
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4.3. Results 
 
The single turnover reactions of rHO-1, IsdG, and IsdI were conducted using ascorbate as 
an electron donor.  HPLC and MS analyses confirm that under the conditions employed in this 
study, the three heme degrading enzymes afford their characteristic tetrapyrrole products (Fig. 
4.2.).  The green product of rHO-1gives a single peak exhibiting a visible absorption maximum 
at 669 nm and a positive mass signal at 586.26, consistent with the formation of biliverdin (m/z 
calculated for C33H34N4O6+H
+
: 611.25).  Two major products of IsdG and IsdI (λmax: ~465 nm) 
exhibit the same mass number, 599.25.  The molecular mass and light absorption properties of 
the IsdG and IsdI products are consistent with those previously reported for the staphylobilin 
isomers (Fig.4.3.) (m/z calculated for C33H34N4O7+H
+
: 599.25).  Additionally, the single 
turnover of MhuD was conducted using ascorbate, not CPR and NADPH described in Chapter 
III, but the reaction condition was slightly different from those of rHO-1, IsdG and IsdI, 
eventually addition of 3 mM desferal and 50 U/ml superoxide dismutase to improve mycobilin 
yields.  Two major purple products of MhuD (λmax: ~340 and 560 nm) have been identified as 
isomers of mycobilin by HPLC analysis and both isomers show a mass peak at 611.25 (m/z 
calculated for C34H34N4O7+H
+
: 611.25) by MS analysis.   
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Figure 4.2. HPLC analysis of tetrapyrrole products of the heme degrading enzymes. (A) HPLC 
chromatograms and (B) light absorption spectra of the chromophores produced by rat HO-1 
(green), MhuD (red), IsdG (purple), and IsdI (cyan).  
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Figure 4.3. Structures of mycobilin isomers and staphylobilin isomers 
 
 
The amount of CO produced was determined by trapping CO by a H64L variant of Mb like 
described in Chapter III.  Figure 4.4. shows the Soret region difference spectra of the ferrous 
H64L Mb induced by CO generated by the single turnover heme degradation.  Like shown in 
Chapter III, while the reaction solution of rHO-1 exhibited a significant difference spectrum, 
essentially no spectral change was observed for MhuD.  IsdG and IsdI exhibited the 
CO-induced difference spectra, but their low intensities indicate low yields of CO (~14%, Fig. 
4.4.).  This finding clearly demonstrates that CO is not the major C1 product of the S. aureus 
enzymes as previously suggested (5). 
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Figure 4.4. CO quantification as difference spectra of H64L Mb upon formation of its ferrous 
CO form.  Spectral changes of ferrous H64L Mb were calculated from the spectra taken before 
and after the heme degradation by 5 μM heme complexes of rat HO-1 (green), MhuD (red), 
IsdG (purple), and IsdI (cyan), respectively. The black broken line represents difference 
spectrum of 5 μM ferrous H64L Mb upon saturation with CO.  
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4.4. Discussion 
 
This study shows that S.aureus IsdG and IsdI do not produce CO as the major C1 product 
although they yield low content percentage of CO.  In fact, my colleague identified one meso 
carbon atom of the porphyrin ring is librated primarily as formaldehyde and secondarily as 
formic acid whose amount is similar to that of CO (Fig. 4.5. and Table 4.1.) (6).  Formaldehyde 
in the reaction solutions of the heme degrading enzymes was converted by an acetylacetone 
method to 3,5-diacetyl-1,4-dihydrolutidine (7), which was quantitated by HPLC analysis.  
Quantitation of formic acid was based on its enzymatic oxidation (8).  Formic acid 
dehydrogenase consumes formic acid to generate an equimolar amount of NADH.   
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 Figure 4.5. HPLC chromatograms for quantitation of C1 products. (A) formaldehyde as 
3,5-diacetyl-1,4-dihydrolutidine and formic acid as NADH produced by rat HO-1 (green), 
MhuD (red), IsdG (purple), and IsdI (cyan), respectively.  Product signals are marked with 
asterisks.  Concentrations of enzymes and standards were 20 μM (formaldehyde) and 50 
μM (formic acid). Figures from Ono’s thesis (6). 
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Table 4.1. Yields of C1 products in the heme degradation
a 
a
Yields are given in percent (%), 
b
n=2, 
c
n=3 
 
 
The absence of CO is first reported for heme degradation by MhuD, in Chapter III, whose 
tetrapyrrole product retains the aldehyde group at the cleavage site.  The similar aldehyde 
formation by IsdG and IsdI are suggestive of their mechanism similarity to MhuD catalysis.  
The low CO yields indicate that IsdG, IsdI, and MhuD do not involve verdoheme, a key 
intermediate of ring cleavage by HO.  In canonical HO catalysis, heme is converted into 
biliverdin by three successive oxygenations, and CO is generated at the second step, 
meso-hydroxyheme to verdoheme (Fig. 4.6.) (3, 9).  Hydroxyheme is highly reactive with 
dioxygen to release CO due to its radical character (3, 10), and this rapid auto-oxidation does 
not require the assistance by the HO enzyme.  Thus, the unique mechanisms of the three 
IsdG-type enzymes appear to be induced by drastic changes in the nature of hydroxyheme (or its 
equivalent).  Since the most remarkable structural feature common to hemes in MhuD, IsdG, 
and IsdI, is their severe non-planarity (4), I propose that the heme ruffling is critical to suppress 
CO production and to promote aldehyde formation upon cleavage of the porphyrin ring.  The 
ruffling can modulate reactivity of hydroxyheme through the large steric distortion and/or by 
changing its electronic configuration (11).  A possible ring opening mechanism of MhuD is 
shonw in Fig. 4. 7.  First step of the mechanism is hydroxyheme takes resonance structure 
which has a ketone at meso position and radical charge at α-pyrrole carbon (keto-enol 
tautomerism).  Next, an oxygen binds to heme iron to form Fe‒ OOH and the terminal oxygen 
atom creates a bond to the α-pyrrole carbon, leading a formation of a bridged intermediate.  
Finally, the consecutive homolysis reactions occur, which lead cleavage of O‒ O bond of the 
bridge and C‒ C bond between α-pyrrole carbon and the meso-carbon, to form an aldehyde at 
the cleavage site (12).  The major difference between the MhuD and IsdG/IsdI reaction is the 
fate of the aldehyde group; retention in the tetrapyrrole by MhuD or release as formaldehyde by 
the S.aureus enzymes.  While deformylation is known to be mediated by a peroxo-heme 
complex, such a nucleophilic deformylation normally librates formic acid (13).  The 
deformylation mechanism, possibly a radical process, is a key to elucidation of the IsdG 
reaction mechanism.  Figure 4.8. shows a possible reaction mechanism of formation of 
enzyme CO
b
 formaldehyde
c
 formic acid
c
 
rHO-1 106 ± 4 4 ± 2 1 ± 1 
MhuD 1 ± 1 4 ± 1 5 ± 1 
IsdG 14 ± 2 82 ± 1 16 ± 1 
IsdI 14 ± 1 81 ± 5 15 ± 1 
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formaldehyde from a mycobilin-like intermediate.  The α-pyrrole carbon possessing aldehyde 
has radical charge and an oxygen molecule creates a bridge between the α-pyrrole carbon and 
heme iron.  the consecutive homolysis reactions occur, which lead cleavage of O‒ O bond of 
the bridge and C‒ C bond between α-pyrrole carbon and the meso-carbon, to form ketone and to 
release a formaldehyde.  There is, however, no evidence that α-pyrrole carbon has radical 
charge. 
 
 
 
Figure 4.6. Possible reaction pathways of HO, MhuD, and IsdG/IsdI. 
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Figure 4.7. The possible ring opening mechanism of MhuD to produce aldehyde from 
hydroxyheme intermediate at the ring cleavage site. 
 
 
 
Figure 4.8. The possible formaldehyde producing mechanism of IsdG and IsdI from MhuD-type 
intermediate possessing formaldehyde at the ring cleave site. 
 
 
Great attention should also be paid with regards to the biological significance of the 
unusual products of the IsdG-type enzymes.  Considering the common absence of CO in the M. 
tuberculosis and S. aureus enzymes, the most probable scenario is that microbes employing the 
IsdG-type enzymes do not favor endogenous production of this toxic gas.  Exogenous CO is 
shown to activate the dormancy regulon of M. tuberculosis at biologically relevant 
concentrations (14) and to have a significant bactericidal effect on S. aureus at high 
concentrations (15).  Moreover, the unique linear tetrapyrroles and formaldehyde may also 
have some biological functions.  In order to elucidate biological significance of the unusual 
heme degradation, re-evaluation of the products are required for some of the IsdG-type enzymes.  
The IsdG enzymes from S.aureus, Bacillus anthracis, and Bradyrhizobium japonicum were first 
reported to produce biliverdin in spite of no observation of the characteristic absorption around 
700 nm (16, 17).  Only the tetrapyrrole product of the S.aureus enzymes was revised recently 
to be staphylobilin (5). 
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In conclusion, I show IsdG and IsdI do not release CO as primary C1 product.  Eventually, 
meso carbon is primarily released as formaldehyde, which is probably due to heme ruffling.  It 
has been postulated that heme ruffling in the IsdG-type enzymes enhances its reactivity while 
controlling the regioselectivity (5, 11).  This study suggests that heme ruffling opens a new 
path for its degradation.  It is of interest to elucidate the novel degradation mechanism and how 
heme ruffling induces this unique reaction.   
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Chapter V 
Conclusions 
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In this study, I have discovered that MhuD catalyzes the heme degradation by an 
unconventional mechanism that may be promoted by the unique heme environment of the 
Mycobacterium tuberculosis enzyme.   
Resonance Raman spectra of ferric monoheme-MhuD are distinct from those of heme 
proteins including HOs but they are similar to those of IsdG (Fig. 2.3. and 2.5.).  The results 
suggest that the active site structure of monoheme –MhuD is similar to that of IsdG and IsdI. 
Further spectroscopic studies of ferrous monoheme-MhuD and mutagenesis studies for ferric 
and ferrous monoheme-MhuD indicate much clearer that the active site of MhuD is similar to 
that of IsdG and IsdI.  The heme axial ligand of MhuD is His75 corresponded to His77 and 
His76 in IsdG and IsdI, respectively, and heme ruffling, which is striking feature of IsdG and 
IsdI, is suggested for monoheme-MhuD by its unusual red-shift of the visible absorption peak of 
ferric-CN MhuD (Fig. 3.4.B).  I conclude that the active site of monoheme-MhuD complex is 
similar to that of IsdG and IsdI including heme ruffling. 
In spite of the structural similarity to IsdG and IsdI, MhuD produces a novel heme 
catabolite, mycobilin, which is distinct from biliverdin and staphylobilin.  Mycobilin retains 
the meso carbon atom at the ring cleavage site as the aldehyde group (Fig. 3.9.).  Consequently, 
CO is not released in the MhuD catalysis and this unprecedented heme degradation by MhuD 
must proceed by a unique reaction mechanism.  In canonical HO catalysis, three successive 
oxygenations convert heme into biliverdin, and CO is generated at the second step, 
meso-hydroxyheme to verdoheme (Fig. 3.12.) (1, 2).  Apparent absence of CO formation 
indicates that the MhuD catalysis does not involve verdoheme, which is the key intermediate of 
ring cleavage by HO. meso-Hydroxyheme has a radical character to promote the reaction with 
dioxygen (1).  As a consequence, the hydroxyheme conversion to verdoheme does not require 
assistance by the HO enzyme (3).  Thus, it is likely that MhuD drastically changes the nature 
of hydroxyheme not to afford verdoheme and CO (Fig. 3.12.).  The ruffling of hydroxyheme is 
suggested to modulate its reactivity through its large steric distortion and/or by changing its 
electronic configuration.  In fact, the ferric heme iron of IsdI is proposed to increase 
susceptibility of the meso-carbon to oxidative attack (4).  This ruffling-mediated product 
change appears to contradict the staphylobilin formation in S. aureus IsdG and IsdI in which one 
meso carbon is postulated to be liberated as CO (5).  This study, however, experimentally 
established that S.aureus IsdG and IsdI do not produce CO as the major C1 product although 
they yield low content percentage of CO.  In IsdG and IsdI, one meso carbon atom of the 
porphyrin ring is librated primarily as formaldehyde and secondarily as formic acid and CO (Fig. 
4.5. and Table 4.1.) (6).  The similar aldehyde formation by IsdG and IsdI are suggestive of 
their mechanism similarity to MhuD catalysis (Fig. 4.7. and 4.8.).   
MhuD shows distinct regioselectivity in ring cleavage and oxidative modification.  In 
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staphylobilin, the macrocycle is cleaved either at β- or δ-meso position (Fig. 3.1.).  The meso 
carbon diagonal to the cleavage site is also oxidized to have a carbonyl group at the δ- or 
β-meso position.  This diagonal oxidation has been rationalized by heme ruffling, which places 
β- and δ-meso carbons proximal to a terminal oxygen atom of the putative iron-dioxygen 
reactive species (5).  In contrast, MhuD cleaves the macrocycle exclusively at the α-meso 
carbon (Fig. 3.9.).  This may be due to a different conformation of heme bound to MhuD 
compared to IsdG and IsdI, whereby heme is rotated about the heme normal.   
In summary, I have discovered that MhuD from M. tuberculosis catalyzes heme 
degradation without generating CO.  In addition, IsdG and IsdI release the formaldehyde as the 
main C1 product but not CO. These findings indicate the presence of an alternative heme 
degradation pathway which is fundamentally distinct from that established for canonical HO.  
This study suggests that heme ruffling opens a new path for its degradation.  It is of interest to 
elucidate the novel degradation mechanism and how heme ruffling induces this unique reaction. 
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